ROBERT E MITTELSTAEDT JR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT E MITTELSTAEDT JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT E MITTELSTAEDT JR. ROBERT E MITTELSTAEDT JR is Director in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and Director in W. P. Carey Inc. ($WPC) and Director in INNOVATIVE SOLUTIONS & SUPPORT INC ($ISSC).
Latest Insider Trading Transactions of ROBERT E MITTELSTAEDT JR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 15 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.26 | 3,090 | 19,343 | 165,629 | 168.7 K to 165.6 K (-1.83 %) |
Mar 11 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.24 | 5,926 | 36,978 | 166,548 | 172.5 K to 166.5 K (-3.44 %) |
Mar 09 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.20 | 5,000 | 31,000 | 172,474 | 177.5 K to 172.5 K (-2.82 %) |
Mar 09 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.20 | 5,926 | 36,741 | 177,474 | 183.4 K to 177.5 K (-3.23 %) |
Mar 05 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.07 | 8,244 | 50,041 | 183,400 | 191.6 K to 183.4 K (-4.30 %) |
Mar 04 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.31 | 3,039 | 19,176 | 191,644 | 194.7 K to 191.6 K (-1.56 %) |
Mar 04 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.31 | 3,039 | 19,176 | 191,644 | 194.7 K to 191.6 K (-1.56 %) |
Feb 26 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 6.54 | 10,000 | 65,400 | 199,683 | 209.7 K to 199.7 K (-4.77 %) |
Jan 06 2021 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 6,872 | 0 | 209,683 | 202.8 K to 209.7 K (+3.39 %) |
Jun 10 2020 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 5.08 | 24,978 | 126,863 | 202,811 | 227.8 K to 202.8 K (-10.97 %) |
Jan 06 2020 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 18,264 | 0 | 227,789 | 209.5 K to 227.8 K (+8.72 %) |
Aug 15 2019 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 5.08 | 14,133 | 71,796 | 209,525 | 223.7 K to 209.5 K (-6.32 %) |
May 13 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 306 | 0 | 0 | |
May 13 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 306 | 0 | 15,515 | 15.2 K to 15.5 K (+2.01 %) |
May 07 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 64.42 | 3,700 | 238,354 | 0 | |
May 07 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 166.30 | 3,700 | 615,310 | 15,209 | 18.9 K to 15.2 K (-19.57 %) |
May 07 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 64.42 | 3,700 | 238,354 | 18,909 | 15.2 K to 18.9 K (+24.33 %) |
Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 306 | 0 | 306 | |
Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,038 | 0 | 0 | |
Feb 14 2019 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,038 | 0 | 15,209 | 14.2 K to 15.2 K (+7.32 %) |
Feb 14 2018 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,038 | 0 | 1,038 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,263 | 0 | 0 | |
Feb 09 2018 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,263 | 0 | 14,171 | 12.9 K to 14.2 K (+9.78 %) |
Jan 03 2018 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 11,494 | 0 | 210,281 | 198.8 K to 210.3 K (+5.78 %) |
Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 75.63 | 5,300 | 400,839 | 0 | |
Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.72 | 367 | 52,378 | 12,908 | 13.3 K to 12.9 K (-2.76 %) |
Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.70 | 100 | 14,270 | 13,275 | 13.4 K to 13.3 K (-0.75 %) |
Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.69 | 2,000 | 285,380 | 13,375 | 15.4 K to 13.4 K (-13.01 %) |
Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.69 | 2,633 | 375,693 | 15,375 | 18 K to 15.4 K (-14.62 %) |
Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 142.68 | 200 | 28,536 | 18,008 | 18.2 K to 18 K (-1.10 %) |
Feb 27 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 75.63 | 5,300 | 400,839 | 18,208 | 12.9 K to 18.2 K (+41.06 %) |
Feb 13 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,560 | 0 | 1,263 | |
Feb 13 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,560 | 0 | 12,908 | 11.3 K to 12.9 K (+13.75 %) |
Feb 09 2017 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,263 | 0 | 2,823 | |
Jan 03 2017 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 14,234 | 0 | 0 | |
Jan 03 2017 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 14,234 | 0 | 198,787 | 184.6 K to 198.8 K (+7.71 %) |
Oct 03 2016 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 14,234 | 0 | 14,234 | |
Aug 08 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 77.58 | 992 | 76,959 | 0 | |
Aug 08 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 140.15 | 992 | 139,027 | 11,348 | 12.3 K to 11.3 K (-8.04 %) |
Aug 08 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 77.58 | 992 | 76,959 | 12,340 | 11.3 K to 12.3 K (+8.74 %) |
Jul 06 2016 | WPC | W. P. Carey Inc. | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 1,155 | 0 | 23,724 | 22.6 K to 23.7 K (+5.12 %) |
Mar 15 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 0.00 | 1,237 | 0 | 1,560 | |
Mar 15 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 0.00 | 1,237 | 0 | 11,348 | 10.1 K to 11.3 K (+12.23 %) |
Feb 11 2016 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,560 | 0 | 2,797 | |
Jan 05 2016 | ISSC | INNOVATIVE SOLUTIO ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 12,307 | 0 | 184,553 | 172.2 K to 184.6 K (+7.15 %) |
Jul 02 2015 | WPC | W. P. Carey Inc. | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 1,346 | 0 | 22,569 | 21.2 K to 22.6 K (+6.34 %) |
Jun 15 2015 | WPC | W. P. Carey Inc. | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 32.24 | 4,000 | 128,960 | 0 | |
Jun 15 2015 | WPC | W. P. Carey Inc. | MITTELSTAEDT ROBERT E JR | Director | Payment of Exercise | F | 61.85 | 2,086 | 129,019 | 21,223 | 23.3 K to 21.2 K (-8.95 %) |
Jun 15 2015 | WPC | W. P. Carey Inc. | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 32.24 | 4,000 | 128,960 | 23,309 | 19.3 K to 23.3 K (+20.72 %) |
May 21 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 59.37 | 1,296 | 76,944 | 0 | |
May 21 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 119.03 | 796 | 94,748 | 10,111 | 10.9 K to 10.1 K (-7.30 %) |
May 21 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 119.02 | 100 | 11,902 | 10,907 | 11 K to 10.9 K (-0.91 %) |
May 21 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 119.01 | 400 | 47,604 | 11,007 | 11.4 K to 11 K (-3.51 %) |
May 21 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 59.37 | 1,296 | 76,944 | 11,407 | 10.1 K to 11.4 K (+12.82 %) |
Mar 13 2015 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 0.00 | 1,237 | 0 | 1,237 | |
Aug 22 2011 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 48.02 | 536 | 25,739 | 0 | |
Aug 22 2011 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 48.02 | 817 | 39,232 | 536 | |
Aug 22 2011 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 48.02 | 536 | 25,739 | 12,644 | 12.1 K to 12.6 K (+4.43 %) |
Aug 22 2011 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 79.96 | 817 | 65,329 | 12,108 | 12.9 K to 12.1 K (-6.32 %) |
Aug 22 2011 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 48.02 | 817 | 39,232 | 12,925 | 12.1 K to 12.9 K (+6.75 %) |
May 13 2011 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 98.49 | 2,600 | 256,074 | 2,600 | |
May 13 2011 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 700 | 0 | 12,108 | 11.4 K to 12.1 K (+6.14 %) |
Sep 10 2010 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | M | 34.25 | 1,896 | 64,938 | 0 | |
Sep 10 2010 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 74.32 | 1,796 | 133,475 | 11,408 | 13.2 K to 11.4 K (-13.60 %) |
Sep 10 2010 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 74.31 | 100 | 7,431 | 13,204 | 13.3 K to 13.2 K (-0.75 %) |
Sep 10 2010 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Buy | M | 34.25 | 1,896 | 64,938 | 13,304 | 11.4 K to 13.3 K (+16.62 %) |
Jul 06 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 40.60 | 41 | 1,665 | 7,801 | 7.8 K to 7.8 K (+0.53 %) |
Jun 03 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 39.99 | 41 | 1,640 | 7,760 | 7.7 K to 7.8 K (+0.53 %) |
May 14 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Option Exercise | A | 38.80 | 1,984 | 76,979 | 1,984 | |
May 14 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 0.00 | 1,288 | 0 | 7,719 | 6.4 K to 7.7 K (+20.03 %) |
May 07 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 40.11 | 3,125 | 125,344 | 6,431 | 9.6 K to 6.4 K (-32.70 %) |
May 07 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Sell | S | 40.13 | 886 | 35,555 | 9,556 | 10.4 K to 9.6 K (-8.48 %) |
May 05 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 40.39 | 41 | 1,656 | 10,442 | 10.4 K to 10.4 K (+0.39 %) |
Apr 02 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 38.41 | 43 | 1,652 | 10,401 | 10.4 K to 10.4 K (+0.42 %) |
Mar 03 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 38.55 | 43 | 1,658 | 10,358 | 10.3 K to 10.4 K (+0.42 %) |
Feb 04 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 40.82 | 40 | 1,633 | 10,315 | 10.3 K to 10.3 K (+0.39 %) |
Jan 05 2004 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 35.77 | 46 | 1,645 | 10,275 | 10.2 K to 10.3 K (+0.45 %) |
Dec 03 2003 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 35.85 | 46 | 1,649 | 10,229 | 10.2 K to 10.2 K (+0.45 %) |
Nov 04 2003 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 34.07 | 48 | 1,635 | 10,183 | 10.1 K to 10.2 K (+0.47 %) |
Oct 06 2003 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 28.97 | 57 | 1,651 | 10,135 | 10.1 K to 10.1 K (+0.57 %) |
Sep 04 2003 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 30.65 | 54 | 1,655 | 10,078 | 10 K to 10.1 K (+0.54 %) |
Sep 04 2003 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 30.65 | 54 | 1,655 | 10,078 | 10 K to 10.1 K (+0.54 %) |
Aug 04 2003 | LH | LABORATORY CORP OF ... | MITTELSTAEDT ROBERT E JR | Director | Grant | A | 31.20 | 53 | 1,654 | 10,024 | 10 K to 10 K (+0.53 %) |
Page: 1